UNSPSC 51282426: Ticarcillin cresyl sodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C22H21N2O6S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0EVR7Q3336, chemically known as p-tolyl (r)-n-((2s,5r,6r)-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl))-3-thiophenemalonamate sodium salt, but more generally known as ticarcillin cresyl sodium, which bears US NIH Compound Identifier 42946.

European Medicines Agency schedules ticarcillin cresyl sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15567MIG. Most nations, for tariff purposes, schedule ticarcillin cresyl sodium under HS 29411090. SMILES: CC1CCC(CC1)OC(=O)[C@H](C2CCSC2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].[NA+].

UNSPSC 51282426 Ticarcillin cresyl sodium is a Commodity code representing a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code does not align with the code's nominal scope. The most recent opportunities tagged to this code involve naloxone and drug deactivation systems (Seminole County, Florida), and doxycycline and ciprofloxacin tablets (Illinois Department of Public Health), neither of which are ticarcillin cresyl sodium or closely related therapeutics. The mismatch suggests either tagging inconsistency in the source data or that state and local procurement systems are using this code as a placeholder for pharmaceutical warehouse and supply-chain contracts without strict adherence to active-ingredient classification.

Recent activity shows issuing bodies in Florida and Illinois procuring pharmaceutical products through competitive bidding and piggyback cooperative purchasing vehicles. Seminole County issued an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride tablets under an invitation-for-bid process. The geographic spread of recent activity is limited to Florida and Illinois based on the available records. Business development professionals should verify that their product or service offering actually corresponds to the specific pharmaceutical active ingredient named in this Commodity code rather than relying on recent opportunity records, which suggest potential classification drift.